Jingyi Jiang

1.2k total citations
42 papers, 853 citations indexed

About

Jingyi Jiang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Jingyi Jiang has authored 42 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Cancer Research. Recurrent topics in Jingyi Jiang's work include interferon and immune responses (8 papers), RNA modifications and cancer (8 papers) and RNA Research and Splicing (8 papers). Jingyi Jiang is often cited by papers focused on interferon and immune responses (8 papers), RNA modifications and cancer (8 papers) and RNA Research and Splicing (8 papers). Jingyi Jiang collaborates with scholars based in China, South Korea and Canada. Jingyi Jiang's co-authors include Jing Yan, Jiamei Wang, Hua‐Qin Wang, Bao-Qin Liu, Huaiyu Qiao, Xiaona Meng, Hao Liang, Chao Li, Chao Li and Chao Li and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Jingyi Jiang

40 papers receiving 845 citations

Peers

Jingyi Jiang
Yao-Qi Huang United States
Jingyi Jiang
Citations per year, relative to Jingyi Jiang Jingyi Jiang (= 1×) peers Yao-Qi Huang

Countries citing papers authored by Jingyi Jiang

Since Specialization
Citations

This map shows the geographic impact of Jingyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyi Jiang more than expected).

Fields of papers citing papers by Jingyi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyi Jiang. The network helps show where Jingyi Jiang may publish in the future.

Co-authorship network of co-authors of Jingyi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyi Jiang. A scholar is included among the top collaborators of Jingyi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyi Jiang. Jingyi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xinren, et al.. (2025). MicroRNA-34a-5p induces cell cycle arrest and leads to spermatogenesis failure by targeting CDC25A. Cellular and Molecular Life Sciences. 82(1). 212–212.
3.
Wang, Xiao, Xi Chen, Qian Luo, et al.. (2023). The CXCR4/miR-1910-5p/MMRN2 Axis Is Involved in Corneal Neovascularization by Affecting Vascular Permeability. Investigative Ophthalmology & Visual Science. 64(4). 10–10. 1 indexed citations
4.
Na, Jing, Lingyu Zhang, Lisha Zheng, et al.. (2022). Static magnetic field regulates proliferation, migration, and differentiation of human dental pulp stem cells by MAPK pathway. Cytotechnology. 74(3). 395–405. 7 indexed citations
5.
Wang, Jiamei, Qi Gao, Hao Liang, et al.. (2021). Implication of BAG5 downregulation in metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(9). 119076–119076. 6 indexed citations
6.
Liang, Hao, Huaiyu Qiao, Jingyi Jiang, et al.. (2021). TRIM29 alters bioenergetics of pancreatic cancer cells via cooperation of miR-2355-3p and DDX3X recruitment to AK4 transcript. Molecular Therapy — Nucleic Acids. 24. 579–590. 14 indexed citations
7.
Qiao, Huaiyu, Qi Zhang, Jiamei Wang, et al.. (2021). TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer. Cancer Letters. 529. 85–99. 29 indexed citations
8.
Liang, Hao, Jiamei Wang, Bao-Qin Liu, et al.. (2020). m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118878–118878. 112 indexed citations
9.
Zhang, Dalin, Jiamei Wang, Jingyi Jiang, et al.. (2020). TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells. Cell Death and Disease. 11(9). 813–813. 24 indexed citations
10.
Wang, Jiamei, Bao-Qin Liu, Qi Zhang, et al.. (2020). ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(4). 118647–118647. 28 indexed citations
11.
Li, Xinyu, Jing Yan, Jia Sun, et al.. (2019). BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(5). 819–827. 13 indexed citations
12.
Wang, Jiamei, Bao-Qin Liu, Chao Li, et al.. (2019). Sestrin 2 protects against metabolic stress in a p53-independent manner. Biochemical and Biophysical Research Communications. 513(4). 852–856. 8 indexed citations
13.
Liu, Yiyao, Chao Ge, Hua Tian, et al.. (2017). The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma.. PubMed Central. 7(6). 1285–1297. 19 indexed citations
14.
Yan, Jing, Feng Du, Jingyi Jiang, et al.. (2017). AUF1 modulates TGF-β signal in renal tubular epithelial cells via post-transcriptional regulation of Nedd4L expression. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(1). 48–56. 10 indexed citations
15.
Jiang, Jingyi, et al.. (2017). Pepsinogen C expression, regulation and its relationship with cancer. Cancer Cell International. 17(1). 57–57. 27 indexed citations
16.
Chen, Kuan‐Fu, et al.. (2016). Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis. PLoS ONE. 11(4). e0153188–e0153188. 31 indexed citations
17.
Yan, Jing, Jingyi Jiang, Xiaona Meng, Yin‐Ling Xiu, & Zhi‐Hong Zong. (2016). MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression. Journal of Experimental & Clinical Cancer Research. 35(1). 31–31. 56 indexed citations
18.
Zheng, Lisha, Jingyi Jiang, Lingyu Zhang, et al.. (2016). Calcium Hydroxide–induced Proliferation, Migration, Osteogenic Differentiation, and Mineralization via the Mitogen-activated Protein Kinase Pathway in Human Dental Pulp Stem Cells. Journal of Endodontics. 42(9). 1355–1361. 38 indexed citations
19.
Zhang, Lijuan, et al.. (2014). Lipopolysaccharides upregulate calcium concentration in mouse uterine smooth muscle cells through the T-type calcium channels. International Journal of Molecular Medicine. 35(3). 784–790. 8 indexed citations
20.
Ruan, Li-Ming, et al.. (2010). High‐intensity focused ultrasound treatment for non‐neoplastic epithelial disorders of the vulva. International Journal of Gynecology & Obstetrics. 109(2). 167–170. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026